FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968679905> ?p ?o ?g. }

• W1968679905 endingPage "2701" @default.
• W1968679905 startingPage "2700" @default.
• W1968679905 abstract "Temocillin, a 6-α-methoxy derivative of ticarcillin, is currently approved for treatment of infections due to members of the Enterobacteriaceae in Belgium and the United Kingdom. It is stable against hydrolysis by most β-lactamases, including extended-spectrum β-lactamases (ESBLs) and AmpC-type β-lactamases, with studies reporting MICs at which 90% of bacteria are inhibited (MIC90s) between 16 and 32 μg/ml (3, 4, 8). Temocillin is thus drawing attention as a potential alternative to carbapenems in treatment of infections caused by the Enterobactericeae producing these broad-spectrum β-lactamases.Carbapenem-resistant Klebsiella pneumoniae producing KPC-type β-lactamase has emerged in recent years and caused hospital outbreaks of serious infections in the United States and other parts of the world (7). Furthermore, KPC-type β-lactamase is increasingly identified in other species of the Enterobacteriaceae as well, including Escherichia coli. One concerning recent phenomenon is the occurrence of urinary tract infections due to KPC-producing organisms at nursing homes (10). Currently, the limited treatment options for infections due to KPC-producing organisms include colistin and tigecycline. Concern over nephrotoxicity due to colistin limits its use outside closely monitored settings, whereas tigecycline does not achieve a therapeutic concentration in urine (2). Furthermore, emergence of resistance to these agents has recently been recorded for the Enterobacteriaceae (5, 6).The present study was conducted to evaluate the in vitro activities of temocillin against clinical isolates of K. pneumoniae and E. coli producing KPC-type β-lactamase. A total of 33 KPC-producing clinical isolates (30 K. pneumoniae isolates and 3 E. coli isolates) were used. KPC production was confirmed by an ertapenem resistance phenotype, a positive modified Hodge test, and positive PCR for the KPC structural gene. The isolates were collected from hospitals in three states in the United States. The MIC of temocillin was determined by the standard agar dilution method (1). Temocillin was provided by Eumedica (Brussels, Belgium). In addition, MICs of temocillin against an E. coli isogenic clone producing KPC-3 were tested to determine the direct effect of KPC production on the temocillin MIC. E. coli ATCC 25922 was used as the control strain.Table ​Table11 summarizes the results. For K. pneumoniae, the MICs ranged between 16 μg/ml and 64 μg/ml (MIC at which 50% of bacteria were inhibited = 32 μg/ml; MIC90 = 32 μg/ml). The E. coli clinical isolates had MICs between 8 and 16 μg/ml. E. coli DH10B both with and without the cloning vector pBCSK− (Stratagene, La Jolla, CA) encoding blaKPC-3 had an MIC of 8 μg/ml. An inoculum effect was not observed at 105 CFU, whereas a mild inoculum effect averaging within a twofold MIC difference was seen with K. pneumoniae when 106 CFU was inoculated (Table ​(Table1).1). This result was in line with those of a previous study documenting a modest inoculum effect of temocillin for non-KPC-producing isolates (9). The frequencies of mutants of representative clinical isolates that grew at their MICs and at 2× MICs were calculated to be approximately 1 × 10−10 and 0 for K. pneumoniae and 3 × 10−10 and 1 × 10−10 for E. coli, respectively.TABLE 1.Susceptibilities of KPC-producing K. pneumoniae and E. coli isolates to temocillinCurrently, the British Society for Antimicrobial Chemotherapy (BSAC) is the only organization that defines temocillin MIC breakpoints for the Enterobacteriaceae. The BSAC defines temocillin susceptibilities at ≤8 and ≤32 μg/ml in systemic and urinary tract infections, respectively (http://www.bsac.org.uk/). One gram of temocillin is known to achieve a peak serum concentration of approximately 160 μg/ml, with serum binding of 85% and a half-life of 4 to 5 h (9). The urinary concentration after a 500-mg dose is approximately 500 μg/ml (9). These pharmacokinetic properties of temocillin make it a potential alternative treatment option for mild to moderate urinary tract infections caused by KPC-producing members of the Enterobacteriaceae." @default.
• W1968679905 created "2016-06-24" @default.
• W1968679905 creator A5006534529 @default.
• W1968679905 creator A5015076483 @default.
• W1968679905 creator A5039242377 @default.
• W1968679905 creator A5068308715 @default.
• W1968679905 creator A5075969337 @default.
• W1968679905 date "2009-06-01" @default.
• W1968679905 modified "2023-10-02" @default.
• W1968679905 title "Activity of Temocillin against KPC-Producing <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i>" @default.
• W1968679905 cites W1902535075 @default.
• W1968679905 cites W2008202704 @default.
• W1968679905 cites W2011742075 @default.
• W1968679905 cites W2026657167 @default.
• W1968679905 cites W2112062046 @default.
• W1968679905 cites W2149587163 @default.
• W1968679905 cites W2151554370 @default.
• W1968679905 cites W2163732007 @default.
• W1968679905 cites W2167065215 @default.
• W1968679905 doi "https://doi.org/10.1128/aac.00290-09" @default.
• W1968679905 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2687206" @default.
• W1968679905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19332667" @default.
• W1968679905 hasPublicationYear "2009" @default.
• W1968679905 type Work @default.
• W1968679905 sameAs 1968679905 @default.
• W1968679905 citedByCount "43" @default.
• W1968679905 countsByYear W19686799052012 @default.
• W1968679905 countsByYear W19686799052013 @default.
• W1968679905 countsByYear W19686799052014 @default.
• W1968679905 countsByYear W19686799052015 @default.
• W1968679905 countsByYear W19686799052016 @default.
• W1968679905 countsByYear W19686799052017 @default.
• W1968679905 countsByYear W19686799052018 @default.
• W1968679905 countsByYear W19686799052019 @default.
• W1968679905 countsByYear W19686799052020 @default.
• W1968679905 countsByYear W19686799052021 @default.
• W1968679905 countsByYear W19686799052022 @default.
• W1968679905 countsByYear W19686799052023 @default.
• W1968679905 crossrefType "journal-article" @default.
• W1968679905 hasAuthorship W1968679905A5006534529 @default.
• W1968679905 hasAuthorship W1968679905A5015076483 @default.
• W1968679905 hasAuthorship W1968679905A5039242377 @default.
• W1968679905 hasAuthorship W1968679905A5068308715 @default.
• W1968679905 hasAuthorship W1968679905A5075969337 @default.
• W1968679905 hasBestOaLocation W19686799052 @default.
• W1968679905 hasConcept C104317684 @default.
• W1968679905 hasConcept C2777058267 @default.
• W1968679905 hasConcept C2778910516 @default.
• W1968679905 hasConcept C2779116282 @default.
• W1968679905 hasConcept C54355233 @default.
• W1968679905 hasConcept C547475151 @default.
• W1968679905 hasConcept C86803240 @default.
• W1968679905 hasConcept C89423630 @default.
• W1968679905 hasConceptScore W1968679905C104317684 @default.
• W1968679905 hasConceptScore W1968679905C2777058267 @default.
• W1968679905 hasConceptScore W1968679905C2778910516 @default.
• W1968679905 hasConceptScore W1968679905C2779116282 @default.
• W1968679905 hasConceptScore W1968679905C54355233 @default.
• W1968679905 hasConceptScore W1968679905C547475151 @default.
• W1968679905 hasConceptScore W1968679905C86803240 @default.
• W1968679905 hasConceptScore W1968679905C89423630 @default.
• W1968679905 hasIssue "6" @default.
• W1968679905 hasLocation W19686799051 @default.
• W1968679905 hasLocation W19686799052 @default.
• W1968679905 hasLocation W19686799053 @default.
• W1968679905 hasLocation W19686799054 @default.
• W1968679905 hasOpenAccess W1968679905 @default.
• W1968679905 hasPrimaryLocation W19686799051 @default.
• W1968679905 hasRelatedWork W1980009488 @default.
• W1968679905 hasRelatedWork W1982073117 @default.
• W1968679905 hasRelatedWork W2086586424 @default.
• W1968679905 hasRelatedWork W2098342846 @default.
• W1968679905 hasRelatedWork W2098721184 @default.
• W1968679905 hasRelatedWork W2275625781 @default.
• W1968679905 hasRelatedWork W2359884160 @default.
• W1968679905 hasRelatedWork W2389129146 @default.
• W1968679905 hasRelatedWork W2392629839 @default.
• W1968679905 hasRelatedWork W2184893515 @default.
• W1968679905 hasVolume "53" @default.
• W1968679905 isParatext "false" @default.
• W1968679905 isRetracted "false" @default.
• W1968679905 magId "1968679905" @default.
• W1968679905 workType "article" @default.